From: Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
Output
10 DEGsa
True Positive
15
True Negative
24
False Positive
1
False negative
2
Sensitivity
88.24
Specificity
96.00
Precision
93.75
F1
90.91
Accuracy
92.86
False Positive Rate
0.0400
False Discovery Rate
0.0625
False Negative Rate
0.0513